ReviewAnnals of oncology : official journal of the European Society for Medical Oncology2011
Advanced breast cancer incidence following population-based mammographic screening.
Review in Annals of oncology : official journal of the European Society for Medical Oncology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
41 citing papers in PubMed, 3 syntheses or guidelines pooled it, 125 citations in OpenAlex.
- Systematic reviews as a 'lens of evidence': Determinants of benefits and harms of breast cancer screening.International journal of cancer · 2019Pooled it
- Statistical analyses in Swedish randomised trials on mammography screening and in other randomised trials on cancer screening: a systematic review.Journal of the Royal Society of Medicine · 2015Pooled it
- Screening for breast cancer with mammography.The Cochrane database of systematic reviews · 2013Pooled it
- Impact of screening on late-stage breast cancer in the Netherlands: a population-based cohort study (2007-2016).Breast (Edinburgh, Scotland) · 2026Article
- Article
- A Systematic Review of the Cost-Effectiveness of Screening Modalities for Breast Cancer in European Countries.Cancers · 2025Review
- A comparison of breast cancer incidence and cancer stages before and after the introduction of the Austrian national breast cancer screening program in the federal state of Salzburg : Real-world data from the Tumor Registry Salzburg.Wiener klinische Wochenschrift · 2025Article
- High-value breast cancer care within resource limitations.The oncologist · 2024Review
- Polysialic acid-functionalized liposomes for efficient honokiol delivery to inhibit breast cancer growth and metastasis.Drug delivery · 2023Article
- Patterns of better breast cancer care in countries with higher human development index and healthcare expenditure: Insights from GLOBOCAN 2020.Frontiers in public health · 2023Article
- A nomogram based on combining clinical features and contrast enhanced ultrasound is not able to identify Her-2 over-expressing cancer from other breast cancers.Frontiers in oncology · 2023Article
- The Impact of Organised Screening Programs on Breast Cancer Stage at Diagnosis for Canadian Women Aged 40-49 and 50-59.Current oncology (Toronto, Ont.) · 2022Article
- Changing Trends in the Proportional Incidence and Five-year Net Survival of Screened and Non-screened Breast Cancers among Women During 1995-2011 in England.Journal of clinical and translational pathology · 2022Article
- Population-level breast screening: how to salvage the concept?Journal of the Royal Society of Medicine · 2020Article
- Mammography screening reduces rates of advanced and fatal breast cancers: Results in 549,091 women.Cancer · 2020Article
- Incidence of advanced-stage breast cancer in regular participants of a mammography screening program: a prospective register-based study.BMC cancer · 2020Article
- The impact of mammography screening programmes on incidence of advanced breast cancer in Europe: a literature review.BMC cancer · 2018Review
- A Review and Comparative Analysis of Information Targeted to the General Public on the Websites of Breast Screening Programs in Canada.Healthcare policy = Politiques de sante · 2017Review
- The impact of the Polish mass breast cancer screening program on prognosis in the Pomeranian Province.Archives of medical science : AMS · 2017Article
- Effect of organised mammography screening on stage-specific incidence in Norway: population study.British journal of cancer · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 4 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBreast cancer mortality is declining in many Western countries. If mammography screening contributed to decreases in mortality, then decreases in advanced breast cancer incidence should also be noticeable. PATIENTS AND
methodsWe assessed incidence trends of advanced breast cancer in areas where mammography screening is practiced for at least 7 years with 60% minimum participation and where population-based registration of advanced breast cancer existed. Through a systematic Medline search, we identified relevant published data for Australia, Italy, Norway, Switzerland, The Netherlands, U.K. and the U.S.A. Data from cancer registries in Northern Ireland, Scotland, the U.S.A. (Surveillance, Epidemiology and End Results (SEER), and Connecticut), and Tasmania (Australia) were available for the study. Criterion for advanced cancer was the tumour size, and if not available, spread to regional/distant sites.
resultsAge-adjusted annual percent changes (APCs) were stable or increasing in ten areas (APCs of -0.5% to 1.7%). In four areas (Firenze, the Netherlands, SEER and Connecticut) there were transient downward trends followed by increases back to pre-screening rates.
conclusionsIn areas with widespread sustained mammographic screening, trends in advanced breast cancer incidence do not support a substantial role for screening in the decrease in mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.